Sharon B. McCullen is a partner in Morgan Lewis's Intellectual Property Practice. Dr. McCullen's practice focuses on intellectual property matters in connection with transactions, strategy, and litigation for specialty chemical companies, pharmaceutical companies, medical device companies and venture capital funds. Dr. McCullen has counseled a diverse group of clients, both domestic and international, in the areas of patent prosecution, patent due diligence, patent validity and freedom to operate opinions, patent strategy and patent portfolio management.
Selected transaction representations include:
- LEO Pharma in its reacquisition of Warner Chilcotts' exclusive products in LEO Pharma's development pipeline.
- Sekisui Chemical Company Ltd. (a subsidiary of Sekisui America Corporation) in the $173 million purchase of Celanese Corporation's polyvinyl alcohol (PVOH) business.
- Pearson plc in its acquisition of Connections Education for $400 million.
Prior to beginning her patent practice, Dr. McCullen worked as a research chemist with the Strategic Research Center of Mobil Oil Corporation, now ExxonMobil Corporation. In connection with this work, the American Chemical Society has recognized Dr. McCullen with its 2007 Heroes of Chemistry Award as a co-inventor of the PxMaxSM process of ExxonMobil Research and Engineering Company. The PxMaxSM process is a selective catalytic process for producing para-xylene and is used throughout the world in petrochemical plants.
U.S. Patent and Trademark Office
Temple University, Beasley School of Law, 2002, J.D. (Law)
University of Illinois, 1982, Ph.D. (Inorganic Chemistry)
University of Kansas, 1977, B.S. (Chemistry)